Scinovex
articleTop 10% cited

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel

Biochemical Pharmacology · 1996 · Vol. 52(12) · pp. 1855–1865
Olivier RixeWaldo OrtuzarManuel ÁlvarezR. R. ParkerEddie ReedK PaullTito Fojo
Cancer Treatment and PharmacologyMetal complexes synthesis and propertiesCancer therapeutics and mechanismsOxaliplatinCisplatinCarboplatinDrugCancerAnticancer drugAntineoplastic DrugsPharmacologyCancer researchCell culture

MeSH terms

OxaliplatinAntineoplastic AgentsCell LineCell SurvivalCisplatinDrug InteractionsDrug ResistanceDrug SynergismHumansOrganoplatinum CompoundsTumor Cells, CulturedCarboplatin
Citations
614
FWCI
4.14
field-weighted impact
References
56
Percentile
94%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel · Scinovex